Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows a new revision label, v3.5.4, replacing the previous v3.5.3. This indicates an update to the page’s versioning metadata.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3 without changing the displayed study details.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check61 days agoChange DetectedThe Italian site entry changes from Padua to Padova (35128).SummaryDifference0.0%

- Check76 days agoChange DetectedNaples, Italy, 80131 was added in place of Napoli, Italy, 80131. The page revision changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This is a minor site update and does not affect the study content.SummaryDifference0.0%

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.